(Q33782762)

29 July 2017

title

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects (English)

1 reference

29 July 2017

1 reference

1 reference

1 reference

Patricia Winokur

4

0 references

Robert L Atmar

8

object named as

Robert L Atmar

1 reference

29 July 2017

6

Robert Belshe

1 reference

29 July 2017

Thomas R Cate

1

1 reference

29 July 2017

Yolanda Rayford

2

1 reference

29 July 2017

Diane Niño

3

1 reference

29 July 2017

Rebecca Brady

5

1 reference

29 July 2017

Wilbur Chen

7

1 reference

29 July 2017

Robert B Couch

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

29 December 2009

1 reference

29 July 2017

1 reference

29 July 2017

volume

28

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

2076-2079

1 reference

Seasonal inactivated influenza virus vaccines

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Neuraminidase inhibitors for influenza

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

An overview of serum antibody responses to influenza virus antigens.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2853016

10.1016/J.VACCINE.2009.12.041

30 October 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference